Alzheon IPO To Fund New Phase III Trialling Of Failed Alzheimer's Drug

 
• By Sten Stovall
  
SC1803_Alzheimers_677117209 _1200.jpg
Alzheon May Need Higher IPO Funding Target If Extra Alzheimer's Trial Needed • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D